Advances in liver fibrosis imaging and hepatocellular carcinoma: Update in 2013

Oncology (Switzerland)

Volumn 84, Issue SUPPL.1, 2013, Pages 1-2

  Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; YTTRIUM 90; APC PROTEIN; DOXORUBICIN; GADOXETIC ACID; IODINATED POPPYSEED OIL; SORAFENIB; UVOMORULIN; VASCULOTROPIN;

CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; DRUG ELUTING STENT; EDITORIAL; ELASTOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; ULTRASOUND; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; GENETIC ASSOCIATION; HEPATITIS B; HEPATITIS C; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PROTEIN METHYLATION; REAL TIME TISSUE ELASTOGRAPHY; RECURRENCE FREE SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

CARCINOMA, HEPATOCELLULAR; ELASTICITY IMAGING TECHNIQUES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 84874346772     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000345882     Document Type: Editorial

References (15)

1. Fujimoto K, Kato M, Kudo M, Yada N, ShiinaT, Ueshima K, et al: Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis inpatients with chronic hepatitis C. Oncology 2013; 84(suppl 1):3-13.
2. Yada N, Morikawa H, Fujimoto K, Kato M, Kawada N, Kudo M: Assessment of liver fibrosis with real-time tissue elastographyin chronic viral hepatitis. Oncology 2013; 84 (suppl 1):14-20.
3. Kudo M, Matsui O, Sakamoto M, Kitao A, Kim T, Ariizumi S, et al: Role of gadoliniumethoxybenzyl- diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan. Oncology 2013; 84(suppl 1):21-27.
4. Takayasu K: Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective. Oncology 2013; 84(suppl 1):28-33.
5. Kim YH, Kim DY: Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know. Oncology2013; 84(suppl 1):34-39.
6. Peng ZW, Chen MS: Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma. Oncology 2013; 84 (suppl 1):40-43.
7. Makino Y, Imai Y, Ohama H, Igura T, Kogita S, Sawai Y, et al: Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Oncology 2013; 84(suppl 1):44-50.
8. Inoue T, Kudo M, Hatanaka K, Arizumi T, Takita M, Kitai S, et al: Usefulness of contrast- enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology 2013; 84(suppl 1):51-57.
9. Minami Y, Kudo M: Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging. Oncology 2013; 84(suppl 1):58-63.
10. Tsai CL, Koong AC, Hsu FM, Graber M, Chen IS, Cheng JCH: Biomarker studies onradiotherapy to hepatocellular carcinoma. Oncology 2013; 84(suppl 1):64-68.
11. Wei J, Zeng ZC: Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/ advanced hepatocellular carcinoma? Oncology 2013; 84(suppl 1):69-74.
12. Minata M, Harada KH, Kudo M, Ikai I, Nishida N: The prognostic value of vascular endothelial growth factor in hepatocellular carcinoma for predicting metastasis after curative resection. Oncology 2013; 84(suppl 1):75-81.
13. Nishida N, Arizumi T, Takita M, Nagai T, Kitai S, Yada N, et al: Quantification of tumor DNA in serum and vascular invasion of human hepatocellular carcinoma. Oncology 2013; 84(suppl 1):82-87.
14. Minata M, Kudo M, Harada KH, Ikai I, Nishida N: Expression of E-cadherin and vascular endothelial growth factor in noncancerous liver is associated with recurrence of hepatocellular carcinoma after curative resection. Oncology 2013; 84(suppl 1):86-90.
15. Nishida N, Kudo M: Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma. Oncology 2013; 84(suppl 1):91-95.